MDTH Could Create Shareholder Value
Analysts at Deutsche Bank upgrade MedCath (NASDAQ: MDTH) from "hold" to "buy." The target price for MDTH is set to $17.
According to Deutsche Bank, MDTH’s potential asset sales could create shareholder value.
MDTH’s shares gained 3.05% to close at $9.47 yesterday. More Analyst Ratings here


























